HVC
NVLN

Healthcare Value Capital’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Healthcare Value Capital’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,400,000
Closed -$1.01M – 24
2019
Q3 		$1.01M Sell
1,400,000
-400,000
-22% -$290K 1.83% 15
2019
Q2 		$1.4M Hold
1,800,000
– – 2.63% 13
2019
Q1 		$2.21M Hold
1,800,000
– – 8.53% 7
2018
Q4 		$1.55M Buy
1,800,000
+788,513
+78% +$891K 6.02% 6
2018
Q3 		$2.99M Sell
1,011,487
-301,900
-23% -$1.07M 7.24% 7
2018
Q2 		$4.83M Buy
1,313,387
+313,387
+31% +$1.26M 13.7% 3
2018
Q1 		$3.5M Hold
1,000,000
– – 14.55% 3
2017
Q4 		$3.12M Buy
1,000,000
+118,560
+13% +$570K 9.49% 4
2017
Q3 		$6.2M Buy
881,440
+50,000
+6% +$401K 12.4% 3
2017
Q2 		$7.67M Hold
831,440
– – 13.79% 2
2017
Q1 		$8.93M Hold
831,440
– – 15.27% 1
2016
Q4 		$7M Buy
+831,440
New +$7.37M 7.5% 4

Other funds holding NVLN

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Healthcare Value Capital's NVLN Position: Q4 2019 in Review

Healthcare Value Capital sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q4 2019, closing a stake of 1,400,000 shares — an estimated $1.01M sold.

Healthcare Value Capital first reported a position in NVLN in Q4 2016 and held it in 12 quarters. The position peaked at $8.93M in Q1 2017. 7 funds tracked by Wall St. Rank hold NVLN as of Q4 2019.

  • Healthcare Value Capital reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q4 2019 after selling out during the quarter.
  • Healthcare Value Capital sold 1,400,000 Novelion Therapeutics Inc. Common Shares shares in Q4 2019, an estimated $1.01M.
  • Healthcare Value Capital first reported a position in Novelion Therapeutics Inc. Common Shares in Q4 2016 and held it in 12 quarters.
  • Healthcare Value Capital's Novelion Therapeutics Inc. Common Shares position peaked at $8.93M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q4 2019.

Based on Healthcare Value Capital's 13F filing for Q4 2019, filed 14 Feb 2020.